Health
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial – The Lancet
Consistent with international society recommendations, renin–angiotensin system inhibitorscan be safely continued in patients admitted to hospital with COVID-19….
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy Terms and Conditions
Continue Reading
-
General19 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News22 hours agoSanta drops in for carols
-
Business23 hours agoHow much upside does Macquarie predict for Sonic Healthcare shares?
-
General13 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
